ETFMG Treatments Testing and Advancements ETF (GERM)

NYSEARCA: GERM · IEX Real-Time Price · USD
+0.23 (1.29%)
At close: Dec 1, 2023, 4:00 PM
-0.54 (-3.02%)
Pre-market: Dec 4, 2023, 7:06 AM EST
Assets $12.48M
Expense Ratio 0.68%
PE Ratio 6.94
Shares Out n/a
Dividend (ttm) $0.22
Dividend Yield 1.22%
Ex-Dividend Date Sep 20, 2023
Payout Ratio 8.49%
1-Year Return -25.26%
Volume 1,285
Open 17.56
Previous Close 17.63
Day's Range 17.57 - 17.86
52-Week Low 15.67
52-Week High 25.07
Beta n/a
Holdings 63
Inception Date Jun 17, 2020

About GERM

Fund Home Page

The ETFMG Treatments Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is issued by ETFMG.

Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol GERM
ETF Provider ETFMG
Index Tracked Prime Treatments, Testing and Advancements Index

Top 10 Holdings

50.43% of assets
Name Symbol Weight
Quest Diagnostics Incorporated DGX 6.91%
Laboratory Corporation of America Holdings LH 6.90%
Alnylam Pharmaceuticals, Inc. ALNY 5.63%
BioNTech SE BNTX 5.50%
Zai Lab Limited ZLAB 4.73%
Moderna, Inc. MRNA 4.55%
Vaxcyte, Inc. PCVX 4.40%
Immunocore Holdings plc IMCR 4.13%
Dynavax Technologies Corporation DVAX 3.93%
ImmunityBio, Inc. IBRX 3.76%
View More Holdings


Ex-Dividend Amount Pay Date
Sep 20, 2023 $0.040 Sep 22, 2023
Jun 21, 2023 $0.060 Jun 23, 2023
Mar 22, 2023 $0.090 Mar 24, 2023
Dec 28, 2022 $0.0286 Dec 30, 2022
Sep 21, 2022 $0.060 Sep 23, 2022
Jun 22, 2022 $0.050 Jun 24, 2022
Full Dividend History


Amplify's Christian Magoon on Purchase of ETFMG's ETFs

In June, the ETF industry learned that issuer ETF Managers Group would be selling its funds to Amplify ETFs. The transaction, once completed, will bring Amplify's total AUM to $8 billion invested acro...

3 months ago - ETF Trends

This Week in ETFs: A Summer Slowdown

The week ending Friday, July 21, has been busy for the ETF industry, though launches were muted. A total of seven funds rolled out, which suggests the market could be entering some kind of summer slum...

4 months ago - ETF Trends

Biotech ETFs Slip After Novavax Cuts 2022 Guidance

Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares Gen...

Other symbols: IDNASBIOXBI
1 year ago - ETF Trends

Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs

Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in i...

Other symbols: BBHIBBQMRNA
1 year ago - ETF Trends

China ETFs Drop On Audit Enforcement

The first tranche of Chinese ADRs affected by a 2020 law has been released.

1 year ago - ETFcom

COVID Biotech ETFs Rise At Fever Pace

ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.

Other symbols: IBBVIRSXBI
2 years ago - ETFcom

Biotech ETFs extend January gains

Biotech exchange-traded funds rallied Monday as investors continued to monitor the sector and its impact on the coronavirus pandemic. The ETFMG Treatments Testing and Advancement ETF gained 4.6% mid-m...

Other symbols: CNCRXBI
3 years ago - Market Watch

First Vaccine ETF Should See Halcyon Days Ahead

There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) said their vaccine delivered an impressive showing in Phase 3 trials. What Happened: Alon...

3 years ago - Benzinga

Investing in coronavirus themed ETFs which focus on companies involved in testing and treatment

ETF Managers Group CEO Sam Masucci discusses GERM an ETF that invests in companies that are focused on COVID-19 treatment and testing.

3 years ago - Yahoo Finance

6 Best Biotech ETFs to Buy for Cutting-Edge Growth

Biotech ETFs are, in a word, hot.

3 years ago - Kiplinger

ETF Open To Close Ratio Jumps

An unusually high number of launches in June boosted the open-to-close ratio. 

Other symbols: BETZWFH
3 years ago - ETFcom

Novavax's 30% surge boosts biotech ETFs to best day in weeks

Exchange-traded funds with exposure to biotech stocks rocketed higher Tuesday on hopeful news about treatments for COVID-19.

Other symbols: NVAXBBC
3 years ago - Market Watch

New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases—but Not Covid-19

The newest health care exchange-traded fund is unique in that three stalwarts of other industry funds aren’t even among its top holdings.

3 years ago - GuruFocus